These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 25176442)

  • 21. Schistosomiasis-from immunopathology to vaccines.
    McManus DP; Bergquist R; Cai P; Ranasinghe S; Tebeje BM; You H
    Semin Immunopathol; 2020 Jun; 42(3):355-371. PubMed ID: 32076812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schistosomes: the road from host-parasite interactions to vaccines in clinical trials.
    Capron A; Riveau G; Capron M; Trottein F
    Trends Parasitol; 2005 Mar; 21(3):143-9. PubMed ID: 15734662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets.
    Sotillo J; Pearson M; Becker L; Mulvenna J; Loukas A
    Int J Parasitol; 2015 Jul; 45(8):505-16. PubMed ID: 25910674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applications for profiling the schistosome transcriptome.
    Gobert GN
    Trends Parasitol; 2010 Sep; 26(9):434-9. PubMed ID: 20605744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Schistosome proteomics: updates and clinical implications.
    Castro-Borges W; Wilson RA
    Expert Rev Proteomics; 2022; 19(4-6):247-261. PubMed ID: 36331139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparative proteomics analysis of the egg secretions of three major schistosome species.
    Carson JP; Robinson MW; Hsieh MH; Cody J; Le L; You H; McManus DP; Gobert GN
    Mol Biochem Parasitol; 2020 Nov; 240():111322. PubMed ID: 32961206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signalling pathways and the host-parasite relationship: putative targets for control interventions against schistosomiasis: signalling pathways and future anti-schistosome therapies.
    You H; Gobert GN; Jones MK; Zhang W; McManus DP
    Bioessays; 2011 Mar; 33(3):203-14. PubMed ID: 21290396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights into the functional biology of schistosomes.
    Walker AJ
    Parasit Vectors; 2011 Oct; 4():203. PubMed ID: 22013990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternatives to Praziquantel for the Prevention and Control of Schistosomiasis.
    Spangenberg T
    ACS Infect Dis; 2021 May; 7(5):939-942. PubMed ID: 32819092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cytoskeleton and motor proteins of human schistosomes and their roles in surface maintenance and host-parasite interactions.
    Jones MK; Gobert GN; Zhang L; Sunderland P; McManus DP
    Bioessays; 2004 Jul; 26(7):752-65. PubMed ID: 15221857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical pharmacology of schistosome TRPA1-like ion channels.
    Bais S; Berry CT; Liu X; Ruthel G; Freedman BD; Greenberg RM
    PLoS Negl Trop Dis; 2018 May; 12(5):e0006495. PubMed ID: 29746471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schistosome syntenin partially protects vaccinated mice against Schistosoma mansoni infection.
    Figueiredo BC; Assis NR; Morais SB; Ricci ND; Pinheiro CS; Martins VP; Bicalho RM; Da'dara AA; Skelly PJ; Oliveira SC
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3107. PubMed ID: 25144756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic modulation, stress and plasticity in susceptibility of the snail host, Biomphalaria glabrata, to Schistosoma mansoni infection.
    Knight M; Ittiprasert W; Arican-Goktas HD; Bridger JM
    Int J Parasitol; 2016 Jun; 46(7):389-94. PubMed ID: 27056272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clusters of polymorphic transmembrane genes control resistance to schistosomes in snail vectors.
    Tennessen JA; Bollmann SR; Peremyslova E; Kronmiller BA; Sergi C; Hamali B; Blouin MS
    Elife; 2020 Aug; 9():. PubMed ID: 32845238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Road to Elimination: Current State of Schistosomiasis Research and Progress Towards the End Game.
    Ogongo P; Nyakundi RK; Chege GK; Ochola L
    Front Immunol; 2022; 13():846108. PubMed ID: 35592327
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cellular distribution and stage-specific expression of two dynein light chains from the human blood fluke Schistosoma japonicum.
    Zhang LH; McManus DP; Sunderland P; Lu XM; Ye JJ; Loukas A; Jones MK
    Int J Biochem Cell Biol; 2005 Jul; 37(7):1511-24. PubMed ID: 15833281
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contributions of the Schistosomiasis Consortium for Operational Research and Evaluation (SCORE) to Schistosomiasis Control and Elimination: Key Findings and Messages for Future Goals, Thresholds, and Operational Research.
    Colley DG; Fleming FM; Matendechero SH; Knopp S; Rollinson D; Utzinger J; Castleman JD; Kittur N; King CH; Campbell CH; Kabole FM; Kinung'hi S; Ramzy RMR; Binder S
    Am J Trop Med Hyg; 2020 Jul; 103(1_Suppl):125-134. PubMed ID: 32400345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of recent findings in schistosome proteomics.
    Driguez P; McManus DP; Gobert GN
    Expert Rev Proteomics; 2016; 13(1):19-33. PubMed ID: 26558506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Schistosomiasis therapeutics: whats in the pipeline?
    Trainor-Moss S; Mutapi F
    Expert Rev Clin Pharmacol; 2016; 9(2):157-60. PubMed ID: 26508363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Schistosoma japonicum IAP and Teg20 safeguard tegumental integrity by inhibiting cellular apoptosis.
    Liu J; Giri BR; Chen Y; Luo R; Xia T; Grevelding CG; Cheng G
    PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006654. PubMed ID: 30044778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.